Hep C Study Finds Big Gender Inequality in Liver Transplant Risks | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Telaprevir Trial Boasts 80% Hepatitis C Cure Rate

Back to News Homepage
Next

Encouraging Test Results for New Hepatitis C Drug

Hep C Study Finds Big Gender Inequality in Liver Transplant Risks

The Editors at Hepatitis Central
November 4, 2009

Print this page

In a large, gender comparison study, researchers found that women with Hepatitis C are more likely than men to have several disadvantages after undergoing a liver transplant.

Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease

ALEXANDRIA, Va. and BOSTON, Oct. 29 /PRNewswire/ — Although women with
chronic hepatitis C virus (HCV) infection are at lower risk for developing
cirrhosis, researchers who compared outcomes for men and women after having
liver transplantation found that women have a significantly increased risk of
overall graft loss and graft loss from recurrent HCV than men. “Given the
higher rate of graft losses due to recurrent HCV and higher risk of developing
advanced HCV, our results highlight the need for close monitoring of HCV
disease progression after liver transplantation and the appropriate timing of
interventions, such as HCV treatment,” said Jennifer Lai, MD, lead
investigator for the study.

Read the entire article:
http://www.reuters.com/article/pressRelease/idUS192100+29-Oct-2009+PRN20091029

No Comments - be the first!
Share
Share
Previous

Telaprevir Trial Boasts 80% Hepatitis C Cure Rate

Back to News Homepage
Next

Encouraging Test Results for New Hepatitis C Drug

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.